Table 2 Effect on renal anemia during study period and changes in nutritional status and CRP
| Â | Saxagliptin | Â | Mitiglinide | Â | ||
|---|---|---|---|---|---|---|
Pre | Post | P value | Pre | Post | P value | |
Hb (g/dL) | 10.5 ± 0.8 | 10.9 ± 0.8 | 0.1523 | 10.7 ± 0.9 | 10.7 ± 0.7 | 0.9855 |
DA (μg/w) | 22.0 ± 22.6 | 16.8 ± 22.1 | 0.2238 | 15.5 ± 10.7 | 19.5 ± 11.5 | 0.1343 |
Fe (mg/dL) | 58.1 ± 21.0 | 73.9 ± 25.0 | 0.0085 | 70.8 ± 34.2 | 68.5 ± 25.9 | 0.733 |
TIBC (mg/dL) | 295.8 ± 58.5 | 296.6 ± 62.1 | 0.921 | 285.4 ± 34.7 | 286.7 ± 50.5 | 0.8657 |
TSAT (%) | 20.2 ± 7.7 | 25.9 ± 10.5 | 0.0148 | 25.3 ± 12.8 | 24.5 ± 9.5 | 0.7349 |
Ferritin (ng/mL) | 58.8 ± 145.0 | 40.3 ± 37.7 | 0.5738 | 33.5 ± 29.7 | 54.1 ± 99.2 | 0.3343 |
DW (kg) | 62.4 ± 9.6 | 62.1 ± 9.9 | 0.3695 | 67.7 ± 18.4 | 68.0 ± 18.6 | 0.7227 |
ERI | 6.9 ± 7.0 | 5.6 ± 8.3 | 0.3769 | 5.0 ± 4.1 | 5.8 ± 3.8 | 0.3522 |
Alb (g/dL) | 3.7 ± 0.3 | 3.8 ± 0.3 | 0.2698 | 3.7 ± 0.3 | 3.7 ± 0.2 | 0.5929 |
TC (mg/dL) | 148.9 ± 38.2 | 148.2 ± 39.7 | 0.852 | 148.4 ± 41.2 | 147.4 ± 41.9 | 0.8656 |
HDL-C (mg/dL) | 43.4 ± 10.9 | 46.0 ± 11.2 | 0.1802 | 38.8 ± 12.0 | 39.3 ± 12.7 | 0.6884 |
LDL-C (mg/dL) | 83.6 ± 26.7 | 83.1 ± 27.8 | 0.8805 | 76.9 ± 24.4 | 81.8 ± 33.3 | 0.276 |
TG (mg/dL) | 126.0 ± 85.0 | 126.6 ± 89.6 | 0.9351 | 187.6 ± 178.4 | 163.2 ± 123.1 | 0.2044 |
CRP (mg/dL) | 0.16 ± 0.17 | 0.17 ± 0.18 | 0.6847 | 0.20 ± 0.26 | 0.33 ± 0.31 | 0.1201 |